CA2623542A1 - Methods of preparing polymers having terminal amine groups using protected amine salts - Google Patents

Methods of preparing polymers having terminal amine groups using protected amine salts Download PDF

Info

Publication number
CA2623542A1
CA2623542A1 CA002623542A CA2623542A CA2623542A1 CA 2623542 A1 CA2623542 A1 CA 2623542A1 CA 002623542 A CA002623542 A CA 002623542A CA 2623542 A CA2623542 A CA 2623542A CA 2623542 A1 CA2623542 A1 CA 2623542A1
Authority
CA
Canada
Prior art keywords
group
polymer
terminal
peg
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002623542A
Other languages
English (en)
French (fr)
Inventor
Hong Zhao
Belen Rubio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Belrose Pharma Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2623542A1 publication Critical patent/CA2623542A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33303Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/321Polymers modified by chemical after-treatment with inorganic compounds
    • C08G65/325Polymers modified by chemical after-treatment with inorganic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3348Polymers modified by chemical after-treatment with organic compounds containing sulfur containing nitrogen in addition to sulfur
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02Polyalkylene oxides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
CA002623542A 2005-10-04 2006-09-29 Methods of preparing polymers having terminal amine groups using protected amine salts Abandoned CA2623542A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/242,656 2005-10-04
US11/242,656 US7601798B2 (en) 2005-10-04 2005-10-04 Methods of preparing polymers having terminal amine groups using protected amine salts
PCT/US2006/038562 WO2007044319A2 (en) 2005-10-04 2006-09-29 Methods of preparing polymers having terminal amine groups using protected amine salts

Publications (1)

Publication Number Publication Date
CA2623542A1 true CA2623542A1 (en) 2007-04-19

Family

ID=37902700

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002623542A Abandoned CA2623542A1 (en) 2005-10-04 2006-09-29 Methods of preparing polymers having terminal amine groups using protected amine salts

Country Status (10)

Country Link
US (2) US7601798B2 (enExample)
EP (1) EP1931313A4 (enExample)
JP (1) JP2009510253A (enExample)
KR (1) KR20080056267A (enExample)
CN (1) CN101321516A (enExample)
AU (1) AU2006302585A1 (enExample)
CA (1) CA2623542A1 (enExample)
IL (1) IL190415A0 (enExample)
TW (1) TW200718730A (enExample)
WO (1) WO2007044319A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007015872A1 (en) * 2005-07-20 2007-02-08 Bridgestone Corporation Amine functionalized polymers
US8133707B2 (en) * 2006-01-17 2012-03-13 Enzon Pharmaceuticals, Inc. Methods of preparing activated polymers having alpha nitrogen groups
JP2009539879A (ja) * 2006-06-09 2009-11-19 エンゾン ファーマスーティカルズ インコーポレイテッド インデノイソキノリン放出性ポリマー複合体
JP2010515762A (ja) * 2007-01-16 2010-05-13 エンゾン ファーマスーティカルズ インコーポレイテッド ポサコナゾール−ポリマー複合体、並びに、ポサコナゾールおよびそのポリマー複合体を使用した治療方法
TWI486169B (zh) * 2007-04-20 2015-06-01 Sigma Tau Rare Diseases S A 酵素性抗癌療法
PL2147116T3 (pl) * 2007-04-20 2016-08-31 Leadiant Biosciences Ltd Stabilna rekombinowana dezaminaza adenozynowa
US20090016985A1 (en) * 2007-07-11 2009-01-15 Enzon Pharmaceuticals, Inc. Polymeric drug delivery system containing a multi-substituted aromatic moiety
KR102122463B1 (ko) 2014-10-14 2020-06-15 할로자임, 아이엔씨 아데노신 디아미네이즈-2(ada2)의 조성물, 이의 변이체 및 이를 사용하는 방법
US12233356B2 (en) 2019-03-21 2025-02-25 Lonza Sales Ag Process for preparing extracellular vesicles
PH12021552223A1 (en) 2019-03-21 2022-05-30 Codiak Biosciences Inc Extracellular vesicles for vaccine delivery
US20230366794A1 (en) 2020-09-23 2023-11-16 Codiak Biosciences, Inc. Process for preparing extracellular vesicles
US20240241020A1 (en) 2020-09-23 2024-07-18 Lonza Sales Ag Process for preparing extracellular vesicles
CN114409890A (zh) * 2022-02-28 2022-04-29 中国科学院长春应用化学研究所 一种氨基功能化的聚乙二醇衍生物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US5643575A (en) * 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US6448369B1 (en) * 1997-11-06 2002-09-10 Shearwater Corporation Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
US6824766B2 (en) * 1998-04-17 2004-11-30 Enzon, Inc. Biodegradable high molecular weight polymeric linkers and their conjugates
WO2000075105A1 (en) * 1999-06-08 2000-12-14 La Jolla Pharmaceutical Company Valency platform molecules comprising aminooxy groups
US20030149307A1 (en) 2001-10-24 2003-08-07 Baxter International Inc. Process for the preparation of polyethylene glycol bis amine
AU2002353814A1 (en) * 2002-10-15 2004-05-04 Baxter Healthcare S.A. Process for the preparation of polyethylene glycol bis amine
US7332164B2 (en) * 2003-03-21 2008-02-19 Enzon Pharmaceuticals, Inc. Heterobifunctional polymeric bioconjugates
KR100512483B1 (ko) * 2003-05-07 2005-09-05 선바이오(주) 신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법
EP1688150A1 (en) * 2005-02-08 2006-08-09 Novo Nordisk A/S Process for the preparation of alkoxyamine functionalised poly ethylene glycols

Also Published As

Publication number Publication date
US20070078219A1 (en) 2007-04-05
KR20080056267A (ko) 2008-06-20
EP1931313A4 (en) 2009-12-23
EP1931313A2 (en) 2008-06-18
TW200718730A (en) 2007-05-16
US20070078257A1 (en) 2007-04-05
CN101321516A (zh) 2008-12-10
WO2007044319A3 (en) 2007-07-12
US7601798B2 (en) 2009-10-13
JP2009510253A (ja) 2009-03-12
AU2006302585A1 (en) 2007-04-19
IL190415A0 (en) 2009-09-22
US7569657B2 (en) 2009-08-04
WO2007044319A2 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
HU228491B1 (en) Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
KR101918339B1 (ko) 다중-아암 폴리에틸렌 글리콜 유도체, 그 유도체의 중간체, 및 그 유도체의 제조방법
US7569657B2 (en) Methods of preparing polymers having terminal amine groups using protected amine salts
JP2003511422A5 (enExample)
WO1997014740A1 (en) Discrete-length polyethylene glycols
WO2007127277A2 (en) Method for preparing multi-arm poly(ethylene glycol) amines
EP1603954A2 (en) Activated forms of water-soluble polymers
EP1928934B1 (en) Methods of preparing polymers having terminal amine groups
EP2279220B1 (en) A method for preparing high-purity polyethyleneglycol aldehyde derivatives
JP5150297B2 (ja) ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
MX2008004375A (en) Methods of preparing polymers having terminal amine groups using protected amine salts
JP5953459B2 (ja) ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
AU2009249967B2 (en) A method for preparing high-purity polyethyleneglycol aldehyde derivatives
CN101248107A (zh) 制备含有末端胺基的聚合物的方法
JP6361083B2 (ja) ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
JP6184462B2 (ja) ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
JP2018115338A (ja) ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140523